The BNP-PL is a multicenter, observational study in which patients are prospectively followed
in order to investigate clinical course and management of pulmonary hypertension in Poland.
All patients diagnosed with pulmonary arterial hypertension and chronic thromboembolic
pulmonary hypertension confirmed in right heart catheterization, will be eligible to
participate in the study.
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.
An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.
Searching Both is inclusive of interventional and observational studies.
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.
Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.
Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.
Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.
The person who is responsible for the scientific and technical direction of the entire clinical study.
Category of organization(s) involved as sponsor (and collaborator) supporting the trial.
The disease, disorder, syndrome, illness, or injury that is being studied.
The BNP-PL Registry is an initiative of the Polish Cardiac Society Task Force for Pulmonary
Vascular Diseases This study is conducted by the Polish Cardiac Society. All centers of
pulmonary hypertension in Poland which are accredited by the National Health Fund have been
invited to join the study. The data is administrated by the Jagiellonian University Medical
College on the basis of an agreement between the Polish Cardiac Society, Jagiellonian
University Medical College and pulmonary hypertension centres.
The goal is to describe current practice and outcomes in patients with pulmonary arterial
hypertension and chronic thromboembolic pulmonary hypertension.
The data collection will have no impact on the way the patient is diagnosed and treated.
Collection of data on patients with pulmonary hypertension is carried out via the electronic
No personal data is entered into the project database.
: PAH adults
Patients with pulmonary arterial hypertension who are at least 18 years old at study entry
: PAH children
Patients with pulmonary arterial hypertension who are at least 3 months old and are less than 18 years old at study entry
Patients with chronic thromboembolic pulmonary hypertension who are at least 18 years old at study entry
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.
Krakowski Szpital Specjalistyczny im. Jana Pawła II
Kraków, , 31-202